Innate raises $9 million in Australian IPO

Innate Immunotherapeutics Ltd. (Auckland, New Zealand) raised A$10 million ($9 million) through the sale of 50 million shares at A$0.20 in an IPO on the Australian Stock Exchange. The price values Innate at A$34.5 million ($30.9 million). Last month, the company filed to raise up to A$12 million ($10.7 million) in the IPO. Patersons Securities and Morgans are joint lead managers. Innate plans to list its shares on ASX on Dec. 22. ...